Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study. Kölsche T, Hagler R, Huntemann N, Masanneck L, Müller M, Kutsojannis B J, Boeckers JM, Kirschner P, Schulze-Bosse K, Aktas O, et al. BMC Neurol. 2026 Aug 21; 26(1). PMID: 42629559. Abstract CommentRecommendBookmarkWatch